Winnergy Medical PCL (BKK:WINMED)
Thailand flag Thailand · Delayed Price · Currency is THB
1.150
-0.020 (-1.71%)
Sep 3, 2026, 4:22 PM ICT

Winnergy Medical PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
16.7915.1729.2630.6460.6765.21
Depreciation & Amortization
47.9348.4950.0644.8740.7933.64
Other Amortization
4.124.12----
Loss (Gain) From Sale of Assets
-19.24-10.53-12.190.710.030.31
Asset Writedown & Restructuring Costs
0.290.29----
Provision & Write-off of Bad Debts
10.9710.971.32.19--
Other Operating Activities
25.3116.515.08-0-6.62-13.16
Change in Accounts Receivable
-13.4614.17-25.94-73.89-62.62-23.67
Change in Inventory
26.21-87.583.06-14.99-9.85-19.6
Change in Accounts Payable
-26.33-38.434.4942.85-47.4535.45
Change in Unearned Revenue
-0.37-2.4384.821.71-2.93
Change in Other Net Operating Assets
15.4218.65180.28-51.12-1.72
Operating Cash Flow
87.64-10.55111.1337.48-74.4773.52
Operating Cash Flow Growth
760.99%-196.51%--802.76%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.93-33.24-178.5-83.58-57.31-122.18
Sale of Property, Plant & Equipment
25.8915.8913.27-0.543.08
Sale (Purchase) of Intangibles
-12.87-6.22-16.39-9.06-6.62-2.57
Investment in Securities
-0.48-----5.65
Other Investing Activities
1.791.47-2.9413.618.08
Investing Cash Flow
-27.6-22.1-181.63-89.7-49.79-119.24

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-77.99-63.4667.35-
Long-Term Debt Issued
-17.6142-4030
Total Debt Issued
-8.1795.5914263.46107.3530
Short-Term Debt Repaid
---42.9---132.78
Long-Term Debt Repaid
--40.77-17.03-16.68-5.59-48.81
Total Debt Repaid
-36.45-40.77-59.93-16.68-5.59-181.6
Net Debt Issued (Repaid)
-44.6254.8282.0746.78101.76-151.6
Issuance of Common Stock
-----359.69
Common Dividends Paid
-5-9.9-11.8-22.76-26-41.69
Other Financing Activities
-15.88-15.82-11.59-8.68-6.31-2.56
Financing Cash Flow
-65.529.158.6815.3469.45163.83

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.45-3.55-11.81-36.88-54.8118.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
45.72-43.79-67.37-46.1-131.78-48.66
Free Cash Flow Growth
------
Free Cash Flow Margin
6.53%-6.77%-10.29%-7.21%-18.73%-9.03%
Free Cash Flow Per Share
0.11-0.11-0.17-0.12-0.33-0.14
Levered Free Cash Flow
22.37-71.13-135.4-106.73-106.11-70.6
Unlevered Free Cash Flow
32.2-61.19-127.79-101.06-101.81-67.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
15.8815.8211.78.86.442.56
Cash Income Tax Paid
1.51.565.826.945.2511.11
Change in Working Capital
1.46-95.5837.62-40.93-169.33-12.47